Omnicell Total Current Liabilities 2010-2025 | OMCL
Omnicell total current liabilities from 2010 to 2025. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
| Omnicell Annual Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $596 |
| 2023 | $368 |
| 2022 | $428 |
| 2021 | $876 |
| 2020 | $276 |
| 2019 | $237 |
| 2018 | $205 |
| 2017 | $205 |
| 2016 | $181 |
| 2015 | $125 |
| 2014 | $112 |
| 2013 | $92 |
| 2012 | $83 |
| 2011 | $61 |
| 2010 | $58 |
| 2009 | $59 |
| Omnicell Quarterly Total Current Liabilities (Millions of US $) |
|
|---|---|
| 2025-03-31 | $608 |
| 2024-12-31 | $596 |
| 2024-09-30 | $962 |
| 2024-06-30 | $407 |
| 2024-03-31 | $416 |
| 2023-12-31 | $368 |
| 2023-09-30 | $369 |
| 2023-06-30 | $370 |
| 2023-03-31 | $454 |
| 2022-12-31 | $428 |
| 2022-09-30 | $377 |
| 2022-06-30 | $374 |
| 2022-03-31 | $951 |
| 2021-12-31 | $876 |
| 2021-09-30 | $339 |
| 2021-06-30 | $317 |
| 2021-03-31 | $292 |
| 2020-12-31 | $276 |
| 2020-09-30 | $234 |
| 2020-06-30 | $237 |
| 2020-03-31 | $248 |
| 2019-12-31 | $237 |
| 2019-09-30 | $228 |
| 2019-06-30 | $211 |
| 2019-03-31 | $211 |
| 2018-12-31 | $205 |
| 2018-09-30 | $213 |
| 2018-06-30 | $202 |
| 2018-03-31 | $221 |
| 2017-12-31 | $205 |
| 2017-09-30 | $206 |
| 2017-06-30 | $212 |
| 2017-03-31 | $197 |
| 2016-12-31 | $181 |
| 2016-09-30 | $198 |
| 2016-06-30 | $191 |
| 2016-03-31 | $200 |
| 2015-12-31 | $125 |
| 2015-09-30 | $123 |
| 2015-06-30 | $138 |
| 2015-03-31 | $109 |
| 2014-12-31 | $112 |
| 2014-09-30 | $112 |
| 2014-06-30 | $103 |
| 2014-03-31 | $92 |
| 2013-12-31 | $92 |
| 2013-09-30 | $99 |
| 2013-06-30 | $89 |
| 2013-03-31 | $86 |
| 2012-12-31 | $83 |
| 2012-09-30 | $79 |
| 2012-06-30 | $73 |
| 2012-03-31 | $62 |
| 2011-12-31 | $61 |
| 2011-09-30 | $61 |
| 2011-06-30 | $59 |
| 2011-03-31 | $59 |
| 2010-12-31 | $58 |
| 2010-09-30 | $58 |
| 2010-06-30 | $57 |
| 2010-03-31 | $59 |
| 2009-12-31 | $59 |
| 2009-09-30 | $61 |
| 2009-06-30 | $59 |
| 2009-03-31 | $55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.446B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.172B | 60.28 |
| Hims & Hers Health (HIMS) | United States | $11.812B | 122.72 |
| Tempus AI (TEM) | United States | $10.155B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.637B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.007B | 62.61 |
| Hinge Health (HNGE) | United States | $3.004B | 0.00 |
| Privia Health (PRVA) | United States | $2.780B | 190.00 |
| Enovis (ENOV) | United States | $1.805B | 10.06 |
| Schrodinger (SDGR) | United States | $1.749B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Phreesia (PHR) | United States | $1.534B | 0.00 |
| Azenta (AZTA) | United States | $1.296B | 60.21 |
| 10x Genomics (TXG) | United States | $1.122B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.634B | 0.00 |
| Claritev (CTEV) | United States | $0.631B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
| Talkspace (TALK) | United States | $0.544B | 162.50 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Standard BioTools (LAB) | United States | $0.378B | 0.00 |
| Outset Medical (OM) | United States | $0.356B | 0.00 |
| TruBridge (TBRG) | United States | $0.353B | 784.00 |
| Health Catalyst (HCAT) | United States | $0.267B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.135B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.124B | 0.00 |
| Pulmonx (LUNG) | United States | $0.120B | 0.00 |
| American Well (AMWL) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.098B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.48 |
| 111 (YI) | China | $0.072B | 0.00 |
| HeartBeam (BEAT) | United States | $0.055B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.036B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| Zhongchao (ZCMD) | China | $0.027B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |